INTERCEPT Trademark

Trademark Overview

On Friday, March 7, 2025, a trademark application was filed for INTERCEPT with the United States Patent and Trademark Office. The USPTO has given the INTERCEPT trademark a serial number of 99073125. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Thursday, November 6, 2025. This trademark is owned by Cerus Corporation. The INTERCEPT trademark is filed in the Pharmaceutical Products category with the following description:

Blood products, namely, platelets, plasma, red blood cells, cryoprecipitate and fibrinogen complex for medical purposes; pathogen inactivated blood for medical purposes; pathogen inactivated blood products, namely, platelets, plasma, red blood cells, cryoprecipitated plasma and fibrinogen complex for medical purposes; pathogen reduced blood products, namely, platelets, plasma, red blood cells, cryoprecipitate and fibrinogen complex for medical purposes.
intercept

General Information

Serial Number99073125
Word MarkINTERCEPT
Filing DateFriday, March 7, 2025
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateThursday, November 6, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesBlood products, namely, platelets, plasma, red blood cells, cryoprecipitate and fibrinogen complex for medical purposes; pathogen inactivated blood for medical purposes; pathogen inactivated blood products, namely, platelets, plasma, red blood cells, cryoprecipitated plasma and fibrinogen complex for medical purposes; pathogen reduced blood products, namely, platelets, plasma, red blood cells, cryoprecipitate and fibrinogen complex for medical purposes.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, March 7, 2025
Primary Code005
First Use Anywhere DateSunday, December 31, 2006
First Use In Commerce DateWednesday, December 31, 2014

Trademark Owner History

Party NameCerus Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressConcord, CA 94520

Trademark Events

Event DateEvent Description
Friday, March 7, 2025NEW APPLICATION ENTERED
Friday, March 7, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, March 7, 2025APPLICATION FILING RECEIPT MAILED
Saturday, August 9, 2025ASSIGNED TO EXAMINER
Saturday, August 9, 2025NON-FINAL ACTION WRITTEN
Saturday, August 9, 2025NON-FINAL ACTION E-MAILED
Saturday, August 9, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, November 5, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, November 5, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, November 5, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, November 6, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, November 6, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, November 6, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, November 6, 2025TEAS AMENDMENT OF USE RECEIVED
Thursday, November 6, 2025USE AMENDMENT FILED
Thursday, November 6, 2025AMENDMENT TO USE PROCESSING COMPLETE

Related Keywords

intercept blood plasma medical purposes complex pathogen fibrinogen products platelets namely